Yield10 Competitors

Delisted . USA . 
Stock . Yield10 Bioscience
YTENDelisted Stock  USD 0.01  0.00  0.00%   
Yield10 Bioscience competes with KS AG, Intrepid Potash, Bioceres Crop, Verde Agritech, and Yara International; as well as few others. The company conducts business under Biotechnology sector and is part of Health Care industry. Analyzing Yield10 Bioscience competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Yield10 Bioscience to its intrinsic valuation because they are able to contrast its competitors on a relative basis. Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.

Yield10 Bioscience vs Corteva Correlation

Pay attention - limited upside

The correlation between Yield10 Bioscience and CTVA is -0.8 (i.e., Pay attention - limited upside) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Yield10 Bioscience and CTVA in the same portfolio, assuming nothing else is changed.

Moving together with Yield10 Stock

  0.68JD JD Inc AdrPairCorr
  0.66HNHPF Hon Hai PrecisionPairCorr

Moving against Yield10 Stock

  0.86MRK Merck CompanyPairCorr
  0.85SAR Saratoga Investment CorpPairCorr
  0.85AA Alcoa CorpPairCorr
  0.81JNJ Johnson JohnsonPairCorr
  0.8ACN Accenture plcPairCorr
Specify up to 10 symbols:
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Yield10 Bioscience's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.010.020.02
Details
Intrinsic
Valuation
LowRealHigh
0.010.010.02
Details
Naive
Forecast
LowNextHigh
0.020.020.02
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
-0.00350.010.02
Details

Yield10 Bioscience Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Yield10 Bioscience and its competitors represents the degree of relationship between the price movements of corresponding delisted stocks. A correlation of about +1.0 implies that the price of Yield10 and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Yield10 Bioscience does not affect the price movement of the other competitor.

High positive correlations

YARIY
+ 0.92
KPLUY
IPI
+ 0.87
KPLUY
BHIL
+ 0.82
BIOX
YARIY
+ 0.8
IPI
LVRO
+ 0.75
BHIL
AVD
+ 0.73
BHIL
  

High negative correlations

BHIL
- 0.88
MBCF
YARIY
- 0.72
BIOX
BIOX
- 0.72
KPLUY
LVRO
- 0.7
MBCF
AVD
- 0.69
MBCF
MBCF
- 0.6
BIOX

Risk-Adjusted Indicators

There is a big difference between Yield10 Stock performing well and Yield10 Bioscience Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Yield10 Bioscience's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
KPLUY  1.63  0.30  0.13  0.41  1.81 
(1.85)
 3.49 
(3.21)
 10.73 
IPI  2.14  0.26  0.12  0.22  2.29 
(2.66)
 6.05 
(3.43)
 11.16 
CGA  0.00  0.00  0.00  0.00  0.00 
 0.00 
 0.00 
 0.00 
 0.00 
BIOX  4.39 (0.46) 0.00 (0.17) 0.00 
 0.00 
 8.70 
(8.37)
 26.94 
MBCF  1.82  0.36  0.13  0.88  1.74 
(2.62)
 3.81 
(2.86)
 21.85 
VNPKF  6.11  0.16  0.01 (8.67) 6.50 
(9.77)
 15.66 
(11.19)
 42.77 
YARIY  1.26  0.22  0.12  0.34  1.46 
(1.31)
 3.25 
(2.48)
 7.61 
BHIL  24.04  1.23  0.05  0.39  25.61 
(33.21)
 71.43 
(51.13)
 231.55 
AVD  2.42 (0.15) 0.00 (0.05) 0.00 
 0.00 
 4.95 
(6.33)
 13.30 
LVRO  7.36  0.48  0.09  0.23  6.33 
(12.84)
 12.33 
(13.33)
 160.48 

Yield10 Bioscience Competitive Analysis

The better you understand Yield10 Bioscience competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Yield10 Bioscience's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Yield10 Bioscience's competition over several years is one of the best ways to analyze its investment potential.
    
 Better Than Average     
    
 Worse Than Peers    View Performance Chart
YTEN KPLUY IPI BIOX MBCF VNPKF YARIY BHIL AVD LVRO
 0.00 
 0.01 
Yield10
 1.60 
 8.23 
KPLUY
 5.26 
 33.16 
Intrepid
 5.83 
 1.13 
Bioceres
 0.49 
 2.03 
Itafos
 3.64 
 1.14 
Verde
 4.75 
 22.49 
Yara
 57.89 
 0.04 
Benson
 2.65 
 4.78 
American
 0.91 
 1.09 
Lavoro
Market Volatility
(90 Days Market Risk)
Somewhat reliable
Not too volatile
Very steady
Dangerous
Very steady
Out of control
Very steady
Very steady
Slightly risky
Out of control
Market Performance
(90 Days Performance)
Weakest
Good
Good
Weakest
Weakest
Soft
Good
Weakest
Weakest
Weak
Odds of Financial Distress
(Probability Of Bankruptcy)
Hazard
Low
Low
Small
Hazard
Low
Low
Hazard
Small
Risky
Current Valuation
(Equity Enterprise Value)
Over Valued
Under Valued
Over Valued
Under Valued
Over Valued
Over Valued
Under Valued
Over Valued
Under Valued
Under Valued
Buy or Sell Advice
(Average Analysts Consensus)
Not Available
Not Available
Strong Sell
Strong Buy
Not Available
Not Available
Not Available
Not Available
Strong Buy
Buy
Trade Advice
(90 Days Macroaxis Advice)
Not Rated
Strong Buy
Strong Buy
Strong Sell
Not Rated
Strong Sell
Strong Buy
Not Rated
Sell
Strong Sell
Current Ratio
6.58
1.73
4.03
1.34
2.23
1.57
1.61
3.92
1.88
N/A
Net Asset
3.91 M
8.74 B
594.52 M
763.65 M
633.85 M
41.4 M
17.27 B
274.76 M
636.72 M
787.77 M
Profit Margin
N/A
0.28
-0.88
-0.18
0.19
0.28
0.12
-0.22
-0.21
-0.1
EBITDA
(14.13 M)
2.45 B
18.76 M
13.59 M
129.15 M
5.29 M
1.93 B
(54.27 M)
(9.43 M)
(337.88 M)
Operating Margin
-7.12
0.31
0.034
0.0892
0.32
0.33
0.16
-0.58
-0.0437
0.0017
Current Valuation
2.07 M
2.66 B
396.45 M
318.01 M
332.04 M
188.29 M
14.54 B
80.24 M
323.57 M
333.42 M
Price To Book
11.23
0.56
0.96
0.3
0.92
6.06
1.45
0.0091
0.63
1.27
Retained Earnings
(414.15 M)
N/A
(172.06 M)
(65.04 M)
N/A
N/A
59.96 B
(523.79 M)
204.88 M
(676.21 M)
Current Asset
15.34 M
1.73 B
195.72 M
102.35 M
N/A
N/A
36.45 B
N/A
236.83 M
N/A
Five Year Return
N/A
2.44
N/A
N/A
N/A
N/A
4.15
N/A
0.43
N/A
Beta
1.43
1.02
1.6
0.47
-1.07
1.15
0.48
2.25
1.23
0.46
Number Of Employees
29
11.04 K
468
751
377
250
37
270
755
3.77 K
Shares Outstanding
692.68 K
382.8 M
13.43 M
63.48 M
188.77 M
52.59 M
509.45 M
6.11 M
28.47 M
114.59 M
Cash Flow From Operations
(10.07 M)
326.9 M
72.5 M
49.91 M
94.5 M
(1.68 M)
1.41 B
(73.13 M)
3.92 M
(160.3 M)
Annual Yield
N/A
0.009
N/A
N/A
N/A
N/A
0.0454
N/A
N/A
N/A
Total Debt
3.21 M
1.08 B
4.25 M
276.61 M
187.01 M
3.08 M
3.09 B
145.83 M
167.81 M
380.33 M
Return On Equity
-15.08
0.27
-0.33
-0.19
0.66
0.56
0.35
-1.58
-0.41
-0.62
Z Score
N/A
2.4
N/A
N/A
0.6
50.4
7.2
N/A
N/A
N/A
Return On Asset
-1.78
0.11
0.0095
-0.0039
0.19
0.24
0.13
-0.16
-0.0162
0.0025
Number Of Shares Shorted
60.7 K
N/A
418.09 K
1.02 M
N/A
N/A
N/A
219 K
833.83 K
41.21 K
Book Value Per Share
-9.71
17.03
37.41
4.08
1.18
0.94
16.86
4.81
7.61
1.35
Current Liabilities
3.91 M
800 M
39.14 M
111.06 M
N/A
N/A
17.58 B
N/A
76.28 M
N/A
Total Asset
3.91 M
8.74 B
594.52 M
763.65 M
633.85 M
41.4 M
17.27 B
274.76 M
636.72 M
787.77 M
Debt To Equity
0.28
0.17
0.002
1.07
0.99
0.22
0.52
0.72
0.33
N/A
Short Ratio
0.03
N/A
3.08
2.6
N/A
N/A
N/A
2.46
4.2
2.99
Target Price
2.5
N/A
24.0
2.0
3.0
N/A
N/A
0.3
12.0
1.88
Last Dividend Paid
N/A
0.2
N/A
N/A
N/A
N/A
5.58
N/A
0.03
N/A
Shares Owned By Institutions
0.03
0.007
64.56
30.72
1.26
1.04
0.01
22.64
69.28
86.34
Market Capitalization
345.46 K
4.35 B
469.94 M
76.17 M
228.77 M
260.33 M
11.58 B
1.52 M
139.78 M
60.75 M
Price To Earning
-3.19
1.73
1.71
513.33
12.87
17.96
15.32
N/A
44.2
N/A
Price To Earnings To Growth
N/A
8.64
0.34
1.95
N/A
N/A
N/A
N/A
2.27
N/A
Price To Sales
0.46
0.72
2.11
0.24
0.38
2.48
0.46
0.0033
0.26
0.0152
Net Income
(14.46 M)
2.98 B
(212.84 M)
(58.85 M)
51.03 M
3.52 M
739 M
(115.31 M)
(126.34 M)
(466.09 M)
Earnings Per Share
-20.14
4.2
-15.2
-0.89
0.59
0.33
4.02
-21.34
-3.98
-1.51
Shares Owned By Insiders
17.54
N/A
19.04
35.75
67.82
23.37
N/A
40.27
8.54
10.16
Revenue
60 K
3.21 B
254.69 M
333.3 M
413.25 M
27.71 M
16.62 B
473.34 M
547.31 M
1.14 B
Working Capital
(3.46 M)
928 M
145.76 M
(29.67 M)
N/A
N/A
18.87 B
17 M
146.54 M
(2.32 B)
Cash And Equivalents
10.16 M
566 M
41.31 M
38.61 M
61.81 M
1.59 M
512 M
210.52 M
12.51 M
N/A
Cash Per Share
2.07
1.48
4.14
0.84
0.33
0.03
1.0
1.02
0.71
N/A
Gross Profit
(6.46 M)
667.8 M
50.55 M
125.43 M
136.88 M
20.58 M
6.55 B
20.01 M
127.8 M
1.37 B
Day Typical Price
0.015
8.21
34.03
1.19
2.03
1.14
22.42
0.0583
4.84
1.09
Accumulation Distribution
N/A
0.0241
0.0732
0.13
0.0049
N/A
0.0093
0.58
0.0382
0.0625
Market Facilitation Index
N/A
0.2
2.62
0.17
0.01
N/A
0.21
0.055
0.19
0.07
Daily Balance Of Power
0.0
0.65
(0.70)
(0.41)
(1.00)
9.2 T
4.857143
(1.00)
(0.68)
(0.14)
Period Momentum Indicator
N/A
0.13
(1.84)
(0.07)
(0.01)
0.04
1.02
(0.06)
(0.13)
(0.01)
Rate Of Daily Change
1.0
1.02
0.95
0.94
1.0
1.04
1.05
0.42
0.97
0.99
Day Median Price
0.015
8.2
34.47
1.21
2.04
1.14
22.39
0.0675
4.88
1.09
Price Action Indicator
N/A
0.095
(2.23)
(0.12)
(0.01)
0.02
0.61
(0.06)
(0.16)
N/A
Relative Strength Index
37.37
64.03
60.18
37.93
46.35
55.27
69.34
37.61
60.04
52.38
Coefficient Of Variation
888.32
589.86
738.48
(1,803)
787.25
5149.49
578.54
2581.64
(6,122)
2767.27
Mean Deviation
29.37
1.63
2.14
4.39
1.82
6.11
1.26
24.04
2.42
7.36
Jensen Alpha
8.58
0.2979
0.2562
(0.46)
0.3573
0.1634
0.2206
1.23
(0.15)
0.4827
Total Risk Alpha
1.62
0.155
0.1087
(0.86)
0.0954
(0.67)
0.122
(2.13)
(0.37)
(1.11)
Sortino Ratio
0.2761
0.1254
0.1242
N/A
0.1342
0.0115
0.122
0.0485
N/A
0.0873
Downside Variance
1169.06
5.31
5.98
N/A
5.66
66.73
2.93
862.86
N/A
49.52
Standard Deviation
84.57
2.17
2.82
5.69
3.13
8.87
1.66
38.83
3.29
19.17
Kurtosis
52.47
0.48
1.07
0.6356
13.71
1.94
0.6889
6.84
0.7922
50.27
Potential Upside
69.23
3.49
6.05
8.7
3.81
15.66
3.25
71.43
4.95
12.33
Treynor Ratio
0.6981
0.4118
0.2195
(0.17)
0.8777
(8.67)
0.3352
0.3889
(0.05)
0.2332
Maximum Drawdown
650.0
10.73
11.16
26.94
21.85
42.77
7.61
231.55
13.3
160.48
Variance
7151.61
4.69
7.96
32.42
9.79
78.6
2.76
1507.78
10.84
367.51
Market Risk Adjusted Performance
0.7081
0.4218
0.2295
(0.16)
0.8877
(8.66)
0.3452
0.3989
(0.04)
0.2432
Risk Adjusted Performance
0.0923
0.1307
0.1065
(0.03)
0.1007
0.0234
0.1321
0.0382
(0)
0.0361
Skewness
6.88
0.0429
0.091
0.7606
2.75
0.9458
0.0308
1.93
0.1305
6.67
Semi Deviation
18.79
1.81
2.29
N/A
1.74
6.5
1.46
25.61
N/A
6.33
Information Ratio
0.1116
0.1334
0.1076
(0.07)
0.102
0.0106
0.1257
0.0367
(0.04)
0.032
Value At Risk
(31.43)
(3.21)
(3.43)
(8.37)
(2.86)
(11.19)
(2.48)
(51.13)
(6.33)
(13.33)
Expected Short fall
(77.13)
(1.85)
(2.66)
N/A
(2.62)
(9.77)
(1.31)
(33.21)
N/A
(12.84)
Downside Deviation
34.19
2.3
2.45
N/A
2.38
8.17
1.71
29.37
N/A
7.04
Semi Variance
352.89
3.28
5.24
N/A
3.02
42.29
2.13
655.94
N/A
40.01

Yield10 Bioscience Competition Performance Charts

Five steps to successful analysis of Yield10 Bioscience Competition

Yield10 Bioscience's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Yield10 Bioscience in relation to its competition. Yield10 Bioscience's competition analysis typically involves several steps, including:
  • Identifying the key players in the market: This involves identifying the major competitors of Yield10 Bioscience in the market, both direct and indirect, as well as new entrants and disruptive technologies.
  • Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
  • Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Yield10 Bioscience's competitive landscape.
  • Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Yield10 Bioscience, and developing a strategy to address them.
  • Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.
Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Yield10 Bioscience position

In addition to having Yield10 Bioscience in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Housewares Thematic Idea Now

Housewares
Housewares Theme
Companies making housewares accessories and providing houseware services. The Housewares theme has 3 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Housewares Theme or any other thematic opportunities.
View All  Next Launch
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.

Other Consideration for investing in Yield10 Stock

If you are still planning to invest in Yield10 Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Yield10 Bioscience's history and understand the potential risks before investing.
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios
Money Managers
Screen money managers from public funds and ETFs managed around the world
Equity Valuation
Check real value of public entities based on technical and fundamental data
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY